Background: Transbronchial cryobiopsy (TBCB) of the lung parenchyma is a minimally invasive alternative for surgical lung biopsy in interstitial lung disease (ILD) patients. Drawbacks are the nondiagnostic rate and complication risk of pneumothorax and bleeding. Fluoroscopy is the current guidance tool for TBCB, which is limited by 2D imaging and a radiation dose for the patient. Confocal laser endomicroscopy (CLE) is a high-resolution imaging technique that provides immediate feedback during bronchoscopy about the elastin fiber network of peripheral lung areas. Both the visceral pleura and fibrotic lung areas consist of elastin fibers and are therefore potentially detectable with CLE. Objectives: To investigate whether CLE is capable of (1) distinguishing fibrotic from normal alveolar areas and (2) identifying the pleura. Methods: In and ex vivo CLE imaging obtained during bronchoscopy was compared with histology of lung biopsies in 14 ILD patients. Results: CLE imaging of the alveolar compartment was feasible in all patients without adverse events. Based on CLE imaging, key characteristics that influence both diagnostic yield (dense fibrotic areas) and complication rate (pleura and subpleural space) were visualized. Conclusions: CLE seems a promising alternative to fluoroscopy as a guidance tool for TBCB procedures.
Introduction
Transbronchial cryobiopsy (TBCB) has recently been introduced as a promising and safer alternative to surgical lung biopsy in the diagnostic approach to diffuse parenchymal lung diseases [1, 2] . However, this technique is hampered by two major limitations; a substantial nondiThis article is licensed under the Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission.
DOI: 10.1159/000493271 agnostic rate (20-30%) [3, 4] and the proportion of complications (pneumothorax and moderate bleeding) of 10-20% [1, [4] [5] [6] [7] .
A recent "Expert Statement" from the Cryobiopsy Working Group formulates evidence-and expert-based suggestions on the procedural aspects of the TBCB procedure [2] . The working group emphasizes that biopsies with distances of less than 1 cm from the pleura are associated with a significantly increased risk of pneumothorax [8] . On the contrary, biopsies obtained too proximally from the middle third of the lung increase the risk of severe bleeding [9] . Therefore, optimal positioning of the cryoprobe with a distance of 1 cm from the pleura is recommended to minimize complications [2] . Furthermore, the working group's recommendation concerning the diagnostic yield of TBCB is that the most densely fibrotic lung parenchyma is of limited diagnostic value and should be avoided [2] .
To date, guidance of the TBCB is performed by fluoroscopy [2, 6, 8] . However, this technique is suboptimal for various reasons: it provides 2D imaging which makes identification of pleura/diaphragm distance challenging and leads to radiation exposure for both the patient and the medical team.
Confocal laser endomicroscopy (CLE) is a rapid laser (488 nm) technique that can be safely combined with standard bronchoscopy and visualizes elastin fibers of the alveolar compartment [10] [11] [12] [13] . Furthermore, the size of the CLE probe (1.4-mm outer diameter) enables it to reach the (sub)pleural region of the lung, which is of specific interest during a TBCB procedure. Both the visceral pleura and fibrotic lung areas consist of elastin fibers and are therefore potentially recognizable with CLE. This provides an opportunity for the CLE technique as a guidance tool for TBCB.
The aim of this pilot study was to investigate whether CLE is capable of (1) distinguishing fibrotic from normal alveolar areas and (2) identifying the pleura.
Methods
Nonsmoking (for at least 3 months) interstitial lung disease (ILD) patients, referred for tissue acquisition of the lung (TBCB or surgical lung biopsies) by a multidisciplinary ILD meeting, were accepted for this study (ClinicalTrials.gov No. NCT02689102) between October 2015 and April 2017. The cryobiopsy procedure was performed under deep sedation in a day clinic setting, with a flexible endotracheal tube for airway management and a prophylactically placed Fogarty balloon in the assessed airway to control bleeding. After the introduction of the bronchoscope a standard bronchoalveolar lavage (BAL) was performed in the contralateral lung. This was followed by fluoroscopy-guided CLE measurements and subsequent fluoroscopy-guided cryobiopsies. The surgical biopsies were performed by video-assisted thoracoscopic surgery. The biopsy locations were previously determined by abnormalities based on a high-resolution CT scan.
The in vivo CLE measurements were performed by inserting the thin (1.4 mm) CLE probe into the working channel of the bronchoscope. From the conducting airways the CLE probe was slowly advanced into the alveolar compartment until the pleura was reached. In each patient several lung segments were assessed and multiple sequences recorded. CLE imaging was performed with the AlveoFlex miniprobe (Mauna Kea Technologies, Paris, France) with a 488-nm wavelength and the following properties: resolution 3.5 µm, depth 0-50 µm, field of view 600 µm. The ex vivo CLE imaging was performed by scanning the biopsy surface by holding the probe in contact with the lung tissue. All CLE imaging was based on autofluorescence; no exogenous fluorescents were used. CLE imaging was analyzed using Cellvizio Viewer software and the automatic mosaic function was used to knit images together for a wider overview. CLE criteria for distinguishing pleura and fibrotic imaging were identified by comparing in and ex vivo CLE imaging to the histology of the lung biopsy. Values are n (%) or mean ± SD, as appropriate. DIP, desquamative interstitial pneumonia; LIP, lymphocytic interstitial pneumonia; NSIP, nonspecific interstitial pneumonia; TBCB, transbronchial cryobiopsy; VATS, video-assisted thoracoscopic surgery. a Only moderate (e.g., requiring endoscopic procedures like bronchial occlusion-collapse and/or instillation of ice-cold saline) and severe (e.g., causing hemodynamic or respiratory instability, requiring tamponade or other surgical interventions, transfusions, or admission to the intensive care unit) bleeding were recorded for this study. Cryobiopsies were fixed in 10% buffered formalin and embedded in paraffin, after which 4-µm-thick sections were cut and stained for elastin fibers (Elastica van Gieson staining), in a routine fashion. The slides were digitalized for analysis by Philips software. The histology images of the lung biopsies were assessed by an experienced pulmonary pathologist (J.J.T.H.R.) and discussed in an ILD multidisciplinary meeting where the final diagnosis was established based on patient history, laboratory blood results, high-resolution CT scan, BAL, and histology from the lung biopsies.
Results
In 14 ILD patients, high-resolution CT imaging, BAL, CLE imaging, and histology of lung biopsy were collected. Patient characteristics, final diagnosis, and complication rate are presented in Table 1 . "CLE imaging of the alveolar compartment was technically feasible in all patients (n = 14), with good quality CLE imaging in 12 patients and moderate quality in 2 patients. On average 3 airway segments imaged with CLE and a separate airway could be imaged in 10-20 s. No adverse events related to the CLE imaging occurred."
On CLE imaging, the pleura with the adjacent alveoli of the subpleural space were visualized (Fig. 1) . Characteristic in and ex vivo CLE pattern of the pleura showed a dense cross-fiber pattern, compatible with the presence of elastin fibers in the histology of visceral pleura (Fig. 1,  right panel) .
We found that on CLE imaging, mild (Fig. 2b) and dense (Fig. 2c) fibrotic lung areas were characterized by a loss of normal (Fig. 2a ) alveolar network structure and increase of elastin fibers. This correlated with the increased amount of elastin and alteration of structure in the histology of the lung biopsies (Fig. 2) .
In those patients with pathology-proven fibrosis (n = 10), CLE imaging was able to visualize both mild and dense fibrotic areas. As pulmonary fibrosis is a heterogeneous disease with an uneven distribution in the alveolar compartment, areas with normal alveoli were alternated by fibrotic lung areas.
Discussion
By comparing in and ex vivo CLE imaging with the histology of lung biopsies we demonstrated that the pleura and fibrotic-affected lung can be identified in a realtime fashion. Therefore, we propose that CLE might qualify as the imaging guidance technique of choice for TBCB.
Integration of the CLE technique in the cryoprobe might overcome the current substantial complication rate (20-30%) by avoiding the pleura and the proximally located larger vasculature. In this study we compared in and ex vivo CLE imaging with pathology and found that CLE was capable of identification of non-, mild, and dense fibrotic areas. Since dense fibrotic areas should be avoided for TBCB, there is potential for CLE as an in vivo high-resolution guidance tool.
In our experience, executing the CLE technique in ILD patients is not time consuming and is easy to perform. Several segments of the lobe of interest could be imaged in a short amount of time, without any adverse events related to the CLE imaging. Currently, the average cost of a CLE procedure is approximately EUR 250.
It has previously been shown that elastin is autofluorescent with the CLE wavelength of 488 nm [10] and that an increase and distortion of the elastin fibers is found in the histology of fibrotic lung [14, 15] , comparable with our CLE findings. The CLE pattern that we found in densely fibrotic areas resembles the previously described (densely packed fiber) pattern by Meng et al. [14] , which they hypothesized to be indicative of late-stage scarring. Uncertainty remained due to the unavailability of histology specimens of cryobiopsy and surgical biopsy as a reference standard. There are no previous studies which assess CLE as a guidance tool for cryobiopsy and only one report about ultrasound-guided cryobiopsy in ILD. In this case series blood vessels could be identified; however, identification of the pleura and areas with dense fibrosis were not described [16] . This study is limited by the small population size. Since ILD is a heterogeneous disease, larger prospective studies should be performed to assess whether the findings apply to different types of ILD. We found a 30% complication rate for TBCB (Table 1) and an 82% diagnostic accuracy, which is comparable to the findings in the literature. In the current study the CLE probe had to be removed prior to the cryobiopsy; therefore real-time identification of the biopsy area by CLE was impossible. An integrated CLE cryoprobe might have reduced the complication and increased the diagnostic yield.
In conclusion, our findings imply that there is potential for CLE as a real-time guidance tool during bronchoscopy with TBCB to optimize the biopsy area, by identify- ing pleura, the subpleural space, and the target fibrotic areas. Whether incorporation of CLE into the cryobiopsy procedure will lead to an actual increase in diagnostic yield and a decrease of the complication risk needs to be determined in larger prospective trials.
